Insiders · Profile

Koppel Adam

Director at Kailera Therapeutics · Director at Solid Biosciences · EVP, Strategy and Bus. Dev. at Biogen · and 1 more. Filing since 25 Jun 2013. CIK 0001578965

Company
Date
Role
Action
Shares
Amount
Of holding
20 Apr 2026
Director
Bought
1,562,500
$25.00M
7.4%
30 Jan 2018
Director
Bought
300,000
$4.80M
17.8%
6 Jun 2016
EVP, Strategy and Bus. Dev.
Sold, plan not stated
555
$160.95K
18.8%
6 Apr 2016
EVP, Strategy and Bus. Dev.
Sold, plan not stated
102
$28.05K
5.2%
25 Jun 2013
Director
Bought
1,250,000
$18.75M
115%
5 decisions on file.